EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,142 | -27.6% | 8,866 | +56.4% | 0.00% | – |
Q2 2023 | $41,611 | +67.9% | 5,667 | +139.5% | 0.00% | – |
Q1 2023 | $24,780 | -37.2% | 2,366 | -29.5% | 0.00% | – |
Q4 2022 | $39,460 | -54.6% | 3,355 | -19.4% | 0.00% | – |
Q3 2022 | $87,000 | -72.9% | 4,165 | -59.7% | 0.00% | -100.0% |
Q2 2022 | $321,000 | -27.9% | 10,323 | -5.8% | 0.00% | 0.0% |
Q1 2022 | $445,000 | -8.2% | 10,958 | -1.5% | 0.00% | 0.0% |
Q4 2021 | $485,000 | -13.9% | 11,120 | -0.8% | 0.00% | 0.0% |
Q3 2021 | $563,000 | -50.4% | 11,210 | -37.7% | 0.00% | -50.0% |
Q2 2021 | $1,135,000 | +7.1% | 17,994 | +56.4% | 0.00% | -33.3% |
Q1 2021 | $1,060,000 | -3.2% | 11,506 | -5.8% | 0.00% | 0.0% |
Q4 2020 | $1,095,000 | -38.1% | 12,210 | -29.0% | 0.00% | -40.0% |
Q3 2020 | $1,770,000 | +19.6% | 17,187 | -7.9% | 0.01% | 0.0% |
Q2 2020 | $1,480,000 | +80.5% | 18,669 | +31.7% | 0.01% | +66.7% |
Q1 2020 | $820,000 | – | 14,174 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |